European Union Pharmaceutical Package: A Summary

Today I’m turning this post over to some of my FTI colleagues in Europe (Antoine Mialhe, Katja Murray and Valeria Fagone among others) who helped summarize the Reform of the EU pharmaceutical legislation that the European Union (EU) adopted on April 26, 2023. The summary below is provided by the FTI Consulting team in Brussels…

What’s at stake if U.S. drug prices fall?

In his 2018 State of the Union address, President Trump said that “fixing the injustice of high drug prices” will be one of the top priorities of his administration in the coming year. Lower drug prices could directly benefit consumers without insurance or those with high-deductible health plans; commercially insured individuals could hope to see…

Cost of Cancer in Europe

In 2008, 2.45 million people were diagnosed with cancer and 1.23 million died because of cancer in the European Union (EU). What is the economic burden of cancer?  A paper by Luengo-Fernandez (2013) aims to estimate just this quantity.  They find that: Cancer cost the EU €126 billion in 2009…Across the EU, the health-care costs…